Cargando…
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
Doxorubicin (DOX), a broad-spectrum chemotherapy drug, is widely applied to the treatment of cancer; however, DOX-induced cardiotoxicity (DIC) limits its clinical therapeutic utility. However, it is difficult to monitor and detect DIC at an early stage using conventional detection methods. Thus, sen...
Autores principales: | Kuang, Ziyu, Wu, Jingyuan, Tan, Ying, Zhu, Guanghui, Li, Jie, Wu, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046787/ https://www.ncbi.nlm.nih.gov/pubmed/36979503 http://dx.doi.org/10.3390/biom13030568 |
Ejemplares similares
-
MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat
por: Piegari, Elena, et al.
Publicado: (2016) -
MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
por: Kawano, Ippei, et al.
Publicado: (2022) -
MicroRNA‐495‐3p diminishes doxorubicin‐induced cardiotoxicity through activating AKT
por: Meng, Jun, et al.
Publicado: (2022) -
MicroRNA expression profiling involved in doxorubicin-induced cardiotoxicity using high-throughput deep-sequencing analysis
por: Chen, Ying, et al.
Publicado: (2021) -
MicroRNA composition of plasma extracellular vesicles: a harbinger of late cardiotoxicity of doxorubicin
por: Totoń-Żurańska, Justyna, et al.
Publicado: (2022)